161 related articles for article (PubMed ID: 23201202)
1. Overexpression of human Argonaute2 inhibits cell and tumor growth.
Zhang X; Graves P; Zeng Y
Biochim Biophys Acta; 2013 Mar; 1830(3):2553-61. PubMed ID: 23201202
[TBL] [Abstract][Full Text] [Related]
2. Acetylation of AGO2 promotes cancer progression by increasing oncogenic miR-19b biogenesis.
Zhang H; Wang Y; Dou J; Guo Y; He J; Li L; Liu X; Chen R; Deng R; Huang J; Xie R; Zhao X; Yu J
Oncogene; 2019 Feb; 38(9):1410-1431. PubMed ID: 30305728
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
4. miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations.
Thomsen KG; Terp MG; Lund RR; Søkilde R; Elias D; Bak M; Litman T; Beck HC; Lyng MB; Ditzel HJ
Oncotarget; 2015 Oct; 6(30):29224-39. PubMed ID: 26317550
[TBL] [Abstract][Full Text] [Related]
5. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
[TBL] [Abstract][Full Text] [Related]
6. Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma.
Cheng N; Li Y; Han ZG
Hepatology; 2013 May; 57(5):1906-18. PubMed ID: 23258480
[TBL] [Abstract][Full Text] [Related]
7. Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells.
Guan G; Li R; Tang W; Liu T; Su Z; Wang Y; Tan J; Jiang S; Wang K
Tumour Biol; 2017 Mar; 39(3):1010428317691740. PubMed ID: 28347232
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma.
Hong X; Yang ZY; Wang M; Lu L; Li YH; Hao X; Chen GY
Int J Mol Med; 2011 Dec; 28(6):953-60. PubMed ID: 21874222
[TBL] [Abstract][Full Text] [Related]
9. Argonaute 2 drives miR-145-5p-dependent gene expression program in breast cancer cells.
Bellissimo T; Tito C; Ganci F; Sacconi A; Masciarelli S; Di Martino G; Porta N; Cirenza M; Sorci M; De Angelis L; Rosa P; Calogero A; Fatica A; Petrozza V; Fontemaggi G; Blandino G; Fazi F
Cell Death Dis; 2019 Jan; 10(1):17. PubMed ID: 30622242
[TBL] [Abstract][Full Text] [Related]
10. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
[TBL] [Abstract][Full Text] [Related]
12. Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.
Prodromaki E; Korpetinou A; Giannopoulou E; Vlotinou E; Chatziathanasiadou Μ; Papachristou NI; Scopa CD; Papadaki H; Kalofonos HP; Papachristou DJ
Cell Oncol (Dordr); 2015 Aug; 38(4):307-17. PubMed ID: 26227789
[TBL] [Abstract][Full Text] [Related]
13. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
Wei X; Zhang K; Qin H; Zhu J; Qin Q; Yu Y; Wang H
BMC Cancer; 2018 May; 18(1):600. PubMed ID: 29843634
[TBL] [Abstract][Full Text] [Related]
14. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.
Yuan S; Yu Z; Liu Q; Zhang M; Xiang Y; Wu N; Wu L; Hu Z; Xu B; Cai T; Ma X; Zhang Y; Liao C; Wang L; Yang P; Bai L; Li Y
Oncogene; 2016 Nov; 35(47):6120-6131. PubMed ID: 27157618
[TBL] [Abstract][Full Text] [Related]
15. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M; Zhou K; Huang Y; Cao Y
J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-519d in lung adenocarcinoma inhibits cell proliferation and invasion via the association of eIF4H.
Bai Y; Lu C; Zhang G; Hou Y; Guo Y; Zhou H; Ma X; Zhao G
Tumour Biol; 2017 Mar; 39(3):1010428317694566. PubMed ID: 28351305
[TBL] [Abstract][Full Text] [Related]
17. Strong reduction of AGO2 expression in melanoma and cellular consequences.
Völler D; Reinders J; Meister G; Bosserhoff AK
Br J Cancer; 2013 Dec; 109(12):3116-24. PubMed ID: 24169347
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of microRNA‑125a‑3p effectively inhibits the cell growth and invasion of lung cancer cells by regulating the mouse double minute 2 homolog/p53 signaling pathway.
Li S; Li X; Zhao H; Gao M; Wang F; Li W
Mol Med Rep; 2015 Oct; 12(4):5482-6. PubMed ID: 26151241
[TBL] [Abstract][Full Text] [Related]
19. MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma.
Pan B; Feng B; Chen Y; Huang G; Wang R; Chen L; Song H
Oncotarget; 2015 Oct; 6(32):32805-20. PubMed ID: 26416454
[TBL] [Abstract][Full Text] [Related]
20. Argonaute 2 promotes myeloma angiogenesis via microRNA dysregulation.
Wu S; Yu W; Qu X; Wang R; Xu J; Zhang Q; Xu J; Li J; Chen L
J Hematol Oncol; 2014 May; 7():40. PubMed ID: 24886719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
